Sensei biotherapeutics to participate in canaccord genuity's horizons in oncology virtual conference

Boston, april 13, 2023 (globe newswire) -- sensei biotherapeutics, inc. (nasdaq: snse), an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that company management will participate in a panel titled ‘overcoming resistance & immunosuppression in solid tumors' at canaccord genuity's horizons in oncology virtual conference on thursday, april 20th at 3:00 p.m. et.
SNSE Ratings Summary
SNSE Quant Ranking